Safety Study of AMI MultiStem® to Treat Heart Attacks
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marc Penn, MD
The Cleveland Clinic
Principal Investigator - Warren Sherman, MD
Columbia University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cardiology Pc
Birmingham, Alabama, United States
- the Care Group
Indianapolis, Indiana, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Columbia University Medical Center
New York, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Metro Health
Cleveland, Ohio, United States
- Hamot Medical Center
Erie, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2008
- Primary completion
- 31 Mar 2010
- Completion
- 29 Feb 2012
- Last update posted
- 11 May 2012
- Registered enrollment
- 25
- Registry id
- NCT00677222
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.